The Diagnosis and Treatment of Pulmonary Infection in Patients Accepted Kidney Transplantation Derived from Donation after the Citizen Death (DCD)

Jiang-qiao ZHOU,Tao QIU,Xiu-heng LIU,Zhi-yuan CHEN,Zhong-bao CHEN,Ye SHEN,Long ZHANG,Lu ZHANG
DOI: https://doi.org/10.3969/j.issn.1674-7410.2015.02.005
2015-01-01
Abstract:Objective To analyze the characteristics and the effect of the diagnosis and treatment of pulmo-nary infection in DCD kidney transplantation. Methods From Jan 2011 to December 2014,69 cases of DCD kid-ney transplantation were analyzed and 129 cases of SCD kidney transplantation were included as the control group. All cases were implemented with antibody induction + tacrolimus (TAC)+ mycophenolate (MMF)+prednisone (Pred)quadruple immunosuppressive scheme. We analyzed the characteristics,therapeutic effect of pulmonary infection after kidney transplantation. Results Followed up for 6~24 months,the overall occurrence rate of pulmonary infection is 17 . 4% vs 33 . 3%. The incidence rate within six months after transplantation is 15. 9% vs 46. 5%. In group DCD,3 cases died of pulmonary infection,while 4 cases in SCD group. The pathogen types mainly included Pneumocystis carinii and cytomegalovirus (CMV). 3 cases in DCD group and 4 cases in SCD group occurred acute rejection during the period of pulmonary infection. The recipient DGF status and the use of ATG were closely related with pulmonary infection. The donor carried with pathogens was not rele-vant to the receiver’s infection. In addition,there were no significant difference of serum creatine before and af-ter treatment . Conclusions There is no significant difference of occurrence rate of pulmonary infection between kidney transplantation receivers of DCD and SCD. The DGF status and ATG application are the two major risk factors. The active treatment can obtain good outcomes.
What problem does this paper attempt to address?